Provided by Tiger Trade Technology Pte. Ltd.

Cadrenal Therapeutics, Inc.

5.84
+0.14002.46%
Volume:14.79K
Turnover:85.15K
Market Cap:13.65M
PE:-0.71
High:5.95
Open:5.71
Low:5.52
Close:5.70
52wk High:22.90
52wk Low:5.34
Shares:2.34M
Float Shares:1.81M
Volume Ratio:0.60
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.1896
EPS(LYR):-8.7339
ROE:-468.03%
ROA:-209.23%
PB:4.99
PE(LYR):-0.67

Loading ...

Dec 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 23, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Dec 01, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities